2025-05-17 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA) based on the data you provided.

## Natera Inc. (NTRA) Analysis

**Company Overview:** Natera Inc. is a diagnostics company focused on cell-free DNA testing, primarily in the areas of reproductive health, oncology, and organ health.

### 1.  Performance vs. S&P 500 (VOO)

*   **Accumulated Return (NTRA):** 126.43%
*   **Accumulated Return (VOO):** 79.33%
*   **Absolute Divergence:** 47.1%
*   **Relative Divergence:** 12.9% (Positioned at the 12.9th percentile of the historical divergence range)

**Analysis:** NTRA has outperformed the S&P 500 significantly over the period examined. The relative divergence suggests that while NTRA is currently outperforming, the margin is not at its historical peak. The fact that the relative divergence is in the lower range suggests that recent outperformance might be less pronounced compared to historical highs.

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2015-2017  | -6.0%  | 62.4% | -32.0%  | -0.1   | 1.2    |
| 2016-2018  | 29.0%  | 80.1% | 14.0%   | 0.2    | 1.9    |
| 2017-2019  | 159.0% | 80.1% | 133.0%  | 0.9    | 4.6    |
| 2018-2020  | 530.0% | 80.1% | 506.0%  | 0.4    | 13.6   |
| 2019-2021  | 356.0% | 62.9% | 303.0%  | 0.2    | 12.8   |
| 2020-2022  | -119.0% | 62.9% | -124.0% | 0.2    | 5.5    |
| 2021-2023  | -482.0% | 69.9% | -498.0% | 1.1    | 8.6    |
| 2022-2024  | -75.0%  | 70.5% | -91.0%  | 1.2    | 21.6   |
| 2023-2025  | 75.0%  | 72.8% | 45.0%   | 0.8    | 20.8   |

*   **CAGR:** Varies widely, demonstrating high growth periods followed by significant declines.
*   **MDD:** Consistently high Maximum Drawdown figures suggest significant volatility.
*   **Alpha:** Shows substantial outperformance in some periods (high positive alpha) and significant underperformance in others (high negative alpha).  This indicates periods where NTRA's returns were significantly better or worse than expected based on the market.
*   **Beta:** Beta values fluctuate, indicating varying degrees of correlation with the market. Some periods show a negative beta, indicating potential for counter-cyclical movement, while others show positive betas, suggesting movement in the same direction as the market.

### 2.  Recent Price Action

*   **Current Price:** $152.59
*   **Previous Close:** $149.40
*   **Change:** $3.19
*   **5-day Moving Average:** $152.58
*   **20-day Moving Average:** $153.05
*   **60-day Moving Average:** $149.03

**Analysis:** NTRA is currently trading above its 60-day moving average but slightly below its 20-day moving average. The price change from the previous close indicates a recent positive movement.

### 3.  Risk and Return Indicators

*   **Market Risk Indicator (MRI):** 0.347 (Low Risk)
*   **RSI:** 49.59 (Neutral)
*   **PPO:** -0.42 (Bearish)
*   **Recent (20-day) Relative Divergence Change:** -1.8 (Short-term Downtrend)
*   **Expected Return:** 166.2% (Long-term)

**Analysis:**

*   The MRI suggests a low-risk environment.
*   The RSI is neutral, indicating neither overbought nor oversold conditions.
*   The negative PPO suggests a bearish trend in price momentum.
*   The negative change in relative divergence confirms a short-term downtrend compared to the S&P 500.
*   The significant price change of $3.19 from the previous close suggests a noticeable market reaction, potentially due to recent news or events.
*   The high expected return suggests substantial potential for long-term outperformance.

### 4.  Recent News & Significant Events

*   **[2025-05-13]:** Major business developments, regulatory changes, or market events.
*   **[2025-05-17]:** Analyst discussions about recent performance and outlook.
*   **[2025-05-15]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-05-16]:** Market experts highlight both risks and opportunities.

**Analysis:** The recent news suggests potential catalysts for price movement, including regulatory changes, analyst opinions, and company-specific events.  The volatility highlighted warrants close monitoring of news and company announcements.

### 5.  Recent Earnings Analysis

| Date       | EPS   | Revenue    |
|------------|-------|------------|
| 2025-05-09 | -0.50 | $0.50 B  |
| 2024-11-12 | -0.26 | $0.44 B  |
| 2024-08-09 | -0.30 | $0.41 B  |
| 2024-05-10 | -0.56 | $0.37 B  |
| 2025-05-09 | -0.56 | $0.37 B  |

**Analysis:** Natera is not yet profitable, with negative EPS figures reported in each quarter. Revenue has been generally increasing, suggesting potential for future profitability.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-03-31   | $0.50B  | 63.12%        |
| 2024-12-31   | $0.48B  | 62.94%        |
| 2024-09-30   | $0.44B  | 61.79%        |
| 2024-06-30   | $0.41B  | 58.83%        |
| 2024-03-31   | $0.37B  | 56.72%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-03-31   | $1.24B    | -5.40%  |
| 2024-12-31   | $1.20B    | -4.50%  |
| 2024-09-30   | $0.88B    | -3.60%  |
| 2024-06-30   | $0.84B    | -4.48%  |
| 2024-03-31   | $0.79B    | -8.51%  |

**Analysis:**

*   **Revenue:**  Consistent growth in revenue over the past five quarters is a positive sign.
*   **Profit Margin:**  Profit margins are also increasing, which suggests improved operational efficiency.  However, it's important to note that even with increasing profit margins, the company is still reporting net losses (as seen in the EPS data).
*   **Equity:**  Increasing equity suggests that the company is growing its asset base.
*   **ROE:** Negative Return on Equity (ROE) reflects the company's current inability to generate profit from shareholders' investments. The improving ROE trend is encouraging, but it remains in negative territory.

### 7.  Overall Analysis

Natera Inc. (NTRA) presents a mixed picture. The company has demonstrated significant historical outperformance compared to the S&P 500, albeit with substantial volatility. Recent performance indicates a slight downtrend, but the current MRI suggests a low-risk environment. While earnings remain negative, revenue and profit margins are improving. The high expected return suggests potential long-term upside, but the negative ROE is not promising. The recent news and events indicate potential catalysts for further price movement.

**Investment Considerations:**

*   **Growth Potential:** Natera operates in a high-growth industry with expanding applications for its technology.
*   **Volatility:** Investors should be prepared for significant price swings.
*   **Profitability:** The company's lack of current profitability is a key risk factor.
*   **News Monitoring:** Staying informed about company-specific news and industry developments is crucial.

In conclusion, NTRA may be suitable for investors with a high-risk tolerance who are seeking potentially high returns and are willing to monitor the company closely. The improving financial metrics and promising expected return warrant further research and consideration.
